跳至主要内容
临床试验/NL-OMON31961
NL-OMON31961尚未招募不适用

Tumorresponse monitoring in patients with breast cancer treated with primary systemic therapy: Towards predicting response in both the primary tumor and in axillary lymph nodes - Tumorresponse monitoring of primary systemic therapy

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion in one of the clinical protocols that are part of the NKI-AVL neoadjuvant therapy program; women with breastcancer > 3 cm and/or axillary lymph node metastasis

排除标准

  • Exclusion in one of the clinical protocols that are part of the NKI-AVL neoadjuvant therapy program; Pregnancy or breastfeeding

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验